iBstone AuraLink vs RxEars Rxi

The iBstone AuraLink is a mid-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.6/5 in HearAdvisor's lab testing. This behind-the-ear device ranks #33 among 65 tested OTC hearing aids, placing it in the top 49% of its category. In our testing, the AuraLink shows a distinctive performance profile with notable strengths in audio entertainment. Music streaming scored a solid 3.6/5, measuring 1.68 points above the category average—a standout result for an OTC device. Feedback handling earned an excellent 5.0/5, sitting 0.46 points above average, meaning users should experience minimal whistling during daily wear. However, speech clarity presents a different picture. Speech in quiet scored a mixed 2.3/5, falling 0.47 points below the category average of 2.79. Speech in noise performance was low at 1.0/5, trailing the already modest category average by 0.48 points. Own-voice comfort scored 2.7/5, slightly above average but only mixed in absolute terms. At $649, the AuraLink faces competition from alternatives offering similar or better sound performance at lower prices, including the iHear MatriX and Olive Union Max. The AuraLink may appeal to users who prioritize music and media streaming over speech enhancement, but those seeking stronger speech clarity should explore other options in this price range.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it represents one of the most affordable options in the prescription hearing aid category while still delivering solid overall performance. Speech clarity is a notable strength for this device. In quiet listening environments, the Rxi scores 4.3/5, which is 0.97 points above the category average—a strong result that should benefit users in conversational settings at home or in calm environments. Speech understanding in noisy conditions scores 2.1/5, slightly above the category average by 0.16 points, though this remains mixed in absolute terms and may present challenges in demanding acoustic situations like busy restaurants. Feedback handling is excellent at 4.7/5, essentially matching the category average and indicating reliable stability during daily wear. However, the Rxi shows notable limitations in other areas. Own-voice comfort scores 1.6/5, falling 1.15 points below the category average, which may result in a hollow or boomy perception of your own voice. Music streaming is not supported, scoring 0.0/5—a significant gap of 2.64 points below category average that buyers should consider if streaming audio matters to them. The RxEars Rxi is best suited for budget-conscious consumers who prioritize speech clarity in quieter environments and don't require streaming capabilities. Its invisible form factor and disposable battery design offer convenience, though those seeking better own-voice comfort or music features should explore alternatives.